27th Annual Pharmacological Conference for Advanced Practice Providers

Course ID: 22CE00002

All times are Central Daylight Time.
Topics, speakers and times are subject to change without notice.

Thursday, July 14th, 2022 (6.25 contact hours/credits)

8:30am Welcome
8:45am-9:45am Immunizations
Daniel W Cramer, MSN, APRN, FNP-C
  • Discuss different types of immunizations and updates related to new vaccines on the market.
  • Describe the clinical consequences of vaccine-preventable diseases in primary care and how to educate patients with comprehensive information about vaccinations and the diseases they prevent.
  • 3. Identify appropriate immunization schedules based on health status and other risk factors for timely and appropriate vaccination.
9:45am-10:45am Care of COVID-19 and Coinfections
Heather Chambers, DNP, APRN-NP, FNP-C
  • Discuss medical management options for hospitalized patients with COVID-19 and other secondary infections.
  • Summarize the differences in treatment options for non-hospitalized patients with COVID-19.
  • Summarize best practice approaches and studies concerning non-FDA approved medications being used for COVID treatment-based case-based scenarios.
11:00am-12:00pm Long Haul COVID
Katie McGill, FNP-C, APRN, BSN
  • Identify symptoms of long-haul COVID to help guide medical management
  • Discuss treatment options for post viral respiratory illnesses related to COVID based on case studies.
  • Describe the incidence of fibrotic disease in COVID-19 patients and how treatment differs
12:30pm-1:15pm Diagnosis and Treatment of ADHD
Meghan Luebbert, DNP, APRN-NP, PMHNP-BC
  • Review diagnostic criteria of ADHD in children and adults
  • Discuss evidence-based pharmacology used to treat ADHD
  • 3Articulate best practice options when initiating pharmaceuticals for ADHD as derived from case studies./li>
1:15pm-2:15pm From Menarche to Menopause: Management of Depression and Anxiety During the Female Reproductive Years
Dana Raml, MD
  • Define depression and anxiety as described by the DSM-5-TR and review how the female reproductive lifespan impacts these diagnoses
  • Describe the pharmacokinetics when prescribing for depression and anxiety while considering the different female reproductive phases involving hormonal changes
  • Discuss best practice approaches for treatment and management of depression and anxiety during reproductive years with an emphasis on pharmacological interventions
  • Utilize case scenarios of patients with anxiety and depression symptoms during various reproductive phases to practice and apply pharmacological treatment strategies
2:30pm-4:00pm Bipolar Disorder: Medication Management in Primary Care
Panel: Margaret Emerson, DNP, APRN, PMHNP-BC; Alisandrea Elson, MD; Melissa O'Dell, MD; Marley Doyle, MD
  • Describe diagnostic criteria for Bipolar Disorder
  • Determine treatment recommendations for management of bipolar disorder
  • Examine common medications and protocols for monitoring treatment for bipolar disorde

Friday, July 15th, 2022 (6.0 contact hours/credits)

8:30am Welcome
8:45am-9:45am Innovation, Improvements, and Interoperability with the PDMP*
Kevin Borcher, PharmD
  • Discuss the opioid epidemic at the state and national level
  • Explain how federal policies and regulations relate to the PDMP and access to optimal pharmaceutical care
  • Demonstrate how the PDMP supports state and federal initiatives to better serve prescription needs of patients.
9:45am-10:45am Opioid Stewardship Updates*
Kristin Daniel, PharmD, BS, BCPS, DPLA
  • Describe best practice guidelines for prescribing naloxone and how to leverage an EMR to improve prescribing practices
  • Review overlooked patient education opportunities for opioids and what can be done to solve the dilemma of unused pills
  • Discuss medical management approaches for the treatment of opioid withdrawal and the tools that can be built in the EMR for multiple healthcare settings
11:00am-12:00pm Pain Management & the PDMP*
Dr. Ally Dering Anderson, PharmD, RP, FAPhA
  • Recognize information that can be found in the Nebraska PDMP
  • Discuss polypharmacy for pain management to reduce opioid doses
  • Describe how to improve naloxone availability for appropriate patients
  • List changes in pain management prescribing as a result of CARA and DATA at the Federal Level
12:45pm-1:45pm Management of Anti-Obesity Medications
Sherri Thomas, DO
  • Discuss the pharmacotherapeutics of anti-obesity medications in primary care and the expectations surrounding patient goals.
  • Articulate the contraindications and side effects when considering medical management of obesity.
  • Describe current FDA approved anti-obesity medications including appropriate dosage and long-term management as derived from case-based approaches.
1:45pm-2:45pm Heart Failure Management in 2022
Teri Diederich, APRN-NP, CHFN, FHFSA
  • Discuss medication initiation and titration for heart failure based on the 2022 heart failure guidelines
  • Identify medication side effects in the treatment of heart failure
  • Describe patient populations eligible for new heart failure pharmaceuticals
3:00pm-4:00pm Update on Immune Checkpoint Inhibitors & Clinical Pearls for Non-Oncology Providers
Lauren Bodhaine-Haywood, PharmD, BCOP, BCPS
  • Review the growing role of immune checkpoint inhibitors (ICI's) in the treatment of patients with cancer
  • Identify best practices for managing adverse effects associated with ICI-targeted therapy
  • Demonstrate prompt recognition of symptoms and early intervention for less common immune-related adverse events
  • Discuss the importance of a multidisciplinary approach to improve the collaborative performance of the interprofessional care team in the medical management of patients with cancer
*applicable towards prescriber 3-hour Opioid Training requirement

If you have questions about this program, please contact Courtney Smith at courtneyl.smith@unmc.edu or at (402) 559-6618.
Send questions or comments about website to the UNMC College of Nursing, Continuing Nursing Education Technical Support concnetechs@unmc.edu